 |
cobicistat |
|---|---|
| Trade Name | Tybost� |
| Orphan Indication | Human immunodeficiency virus type 1 (HIV-1) infection in pediatric patients |
| USA Market Approval | USA |
| USA Designation Date | 2017-06-15 00:00:00 |
| Sponsor | Gilead Sciences, Inc.;333 Lakeside Drive;Foster City, California, 94404 |
